Developing dual PAR1/KLK6 inhibitors based on bi-specific APPI peptide-small molecule conjugates for clinical translation as therapeutic anticancer agents

Number of publications: 0
Israeli Partner: N. Papo, Ben-Gurion Univ.
German Partner: A. Miller, DKFZ

No publications available.

to top